Pulse Explorar nav.journalClub Debates Tendencias Investigadores Revistas

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

Dapagliflozin vs. metolazone in heart failure resistant to loop diuretics | Synapse

May 21, 2023Open Access

Ver artículo completo

Dapagliflozina vs. metolazona en insuficiencia cardíaca resistente a diuréticos de asa

SYSu Ern YeohEvolved Analytics (United States)JOJoanna OsmanskaBritish Heart Foundation

Mark C. PetrieHeart Failure / Cardiomyopathy

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Identificador de ClinicalTrials.gov: NCT04860011.

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Yeoh et al. (Sun,) estudiaron esta cuestión.

synapsesocial.com/papers/69dcca255f911386753596bb https://doi.org/https://doi.org/10.1093/eurheartj/ehad341

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial2022 · 303 citations
2Ultrafiltration Versus Intravenous Diuretics for Patients Hospitalized for Acute Decompensated Heart Failure2007 · 1,114 citations
3Why do <scp>SGLT2</scp> inhibitors reduce heart failure hospitalization? <scp>A</scp> differential volume regulation hypothesis2017 · 485 citations
4Localizations of Na+-d-glucose cotransporters SGLT1 and SGLT2 in human kidney and of SGLT1 in human small intestine, liver, lung, and heart2014 · 288 citations
5Diuretic Strategies for Loop Diuretic Resistance in Acute Heart Failure2019 · 184 citations